Picard Medical is trading at $7.80, up 5.12% in after-hours trading; a sharply higher broader market may have supported the move, but no direct cause was established. - The supplied market context showed gains in the S&P 500, Nasdaq and Dow. - No November 4 company-specific announcement explaining the move was identified; Picard Medical’s investor-relations release page lists no release dated November 4. - The permanent CEO appointment was announced earlier and was not a new November 4 catalyst.